Company: TCPA
Filing Date: 2025-02-20
Form Type: SUPPL
Source: 0001193125-25-030844
Chunk: 74

Company: TRANSCANADA PIPELINES LTD
Filing Date: 2025-02-20
Form: SUPPL
Chunk 74
---
 Notes of TCPL due 2031; (v) the repurchase on October 15, 2024 of
U.S.$200,842,000 aggregate principal amount of 5.000% Senior Notes of TCPL due 2043; (vi) the repurchase on October 15, 2024 of U.S.$440,800,000aggregate principal amount of 4.875%Senior Notes of TCPL due 2048; (vii) the
repurchase on October 15, 2024 of U.S.$180,024,000aggregate principal amount of 5.100%Senior Notes of TCPL due 2049; (viii) the repurchase on October 15, 2024 of U.S.$313,560,000aggregate principal amount of
4.750%Senior Notes of TCPL due 2038; (ix) the redemption on October 31, 2024 of U.S.$850,000,000aggregate principal amount of 6.203%Senior Notes of TCPL due 2026; (x) the redemption on October 31, 2024 of
U.S.$400,000,000 aggregate principal amount of Floating RateSenior Notes of TCPL due 2026; (xi) the redemption on October 31, 2024 of $600,000,000aggregate principal amount of 5.419%Medium Term Notes of TCPL due 2026;
and (xii) the redemption on October 31, 2024 of $400,000,000aggregate principal amount of Floating RateMedium Term Notes of TCPL due 2026, there have been no material changes in the share and loan capital of TCPL, on a
consolidated basis, since September 30, 2024.

USE OF PROCEEDS

Unless otherwise specified in the applicable prospectus supplement, we intend to use the net proceeds from the sale of debt securities to
reduce or repay indebtedness and/or to, directly or indirectly, finance the Corporation’s long-term investment program. Specific information about the use of net proceeds will be set forth in the applicable prospectus supplement. The
Corporation may invest funds that it does not immediately require in short-term marketable investment grade securities. The Corporation may, from time to time, issue debt securities other than pursuant to this prospectus.

7

EARNINGS COVERAGE

Information regarding earnings coverage ratios will be provided in the applicable prospectus supplement relating to